Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01418014 · ClinicalTrials.gov registry record
Adolescent Master Protocol
A clinical trial, sponsored by Harvard School of Public Health (HSPH).
- Completed
- Registry status
- 678
- Enrollment target
NCT01418014 is a clinical trial that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 678 participants.
The verdict
NCT01418014 has completed, sponsored by Harvard School of Public Health (HSPH).
- COMPLETED
- Registry status
- 678 participants
- Enrollment target
Study Summary
The advances in treatment to prevent maternal HIV transmission to neonates have been groundbreaking. As a result, the number of new perinatally-infected children in the U.S. is now small. Subsequent improvements in the treatment of HIV-infected infants and children have been equally remarkable, ensuring that most previously infected American children have survived and are approaching adolescence. In addition, the number of HIV-infected adolescents worldwide is growing substantially in both resource-poor countries and in countries with increasing levels of health care. Therefore, there is a global cohort of children who have been living with HIV infection since birth who are aging into adolescence. Little is definitively known about the impact of HIV infection and its treatment on the maturation process in these children. AMP is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy on pre-adolescents and adolescents with perinatal HIV infection. Domains to be investigated include growth and sexual maturation, metabolic risk factors for cardiovascular disease, cardiac function, bone health, neurologic, neurodevelopment, language, hearing and behavioral function, and sexually transmitted infections (STI).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2007-03 |
| Est. Completion | 2021-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01418014
The ClinicalTrials.gov registry entry for NCT01418014 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 678 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01418014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01418014 about?
NCT01418014 is a clinical study titled "Adolescent Master Protocol". The advances in treatment to prevent maternal HIV transmission to neonates have been groundbreaking. As a result, the number of new perinatally-infected children in the U.S. is now small. Subsequent improvements in the treatment of HIV-infected infants and children have been equally remarkable, ensu...
What is the current status of trial NCT01418014?
This trial is currently completed. The enrollment target is 678 participants. The study started on 2007-03. Estimated completion is 2021-02.
Who is sponsoring clinical trial NCT01418014?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.